Skip to content

RCFS News

RCFS Winter Conference: Decisions

Decisions for submitted papers and registered reports have been sent. If you selected dual submission, you will receive a separate email in the coming weeks.

Call for Papers: 11th MoFiR Workshop on Banking

The 11th MoFiR Workshop on Banking is now accepting submissions. Please see the Call for Papers. The workshop, which features a dual submission option with RCFS, will take place in Lisbon on July 5-6, 2022. The RCFS sponsoring editor is Andrew Ellul. The submission deadline is 6pm (GMT), Sunday January 30, 2022. 

Forthcoming Paper

“Do Ex-Bankers Benefit Non-Financial Firms? Evidence from Job Transitions” by Lucy Chernykh and Sergey Mityakov

Forthcoming Papers

“Passivity on the Board of Directors” by Chris Yung “Racial Disparities in Mortgage Lending: New Evidence based on Processing Time” by Bin Wei Federal and Feng Zhao

Paper Spotlight: Public Firm Borrowers of the U.S. Paycheck Protection Program

The Paycheck Protection Program (PPP), with over $500 billion distributed over a few months in 2020, was one of the largest stimulus programs in U.S. history. The program was created to help “small businesses” survive the COVID-19 shock. However, in a forthcoming RCFS paper, “Public Firm Borrowers of the U.S. Paycheck Protection Program,” Anna Cororaton and Samuel Rosen document that nearly half of U.S. public firms were eligible for the… Read More »Paper Spotlight: Public Firm Borrowers of the U.S. Paycheck Protection Program

Editor’s Choice 10(4)

The Editor’s Choice paper for issue 10(4) is “Public Firm Borrowers of the U.S. Paycheck Protection Program” by Anna Cororaton and Samuel Rosen. You can read the paper free online.

Paper Spotlight: Sharing R&D Risk in Healthcare via FDA Hedges

                          Recent estimates suggest that the cost of developing a single new drug in the biopharmaceutical sector is $2.6 billion, confirming the very large amounts of money that medical companies invest to develop a new treatment. Biomedical companies also face the risk of very low rates of success, not only due to the inherent scientific risk of developing… Read More »Paper Spotlight: Sharing R&D Risk in Healthcare via FDA Hedges

Forthcoming Paper

“Hidden Performance: Salary History Bans and Gender Pay Gap” by Jesse Davis, Paige Parker Ouimet, and Xinxin Wang